Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
ProQR Therapeutics N.V. (PRQR) had Income from Continuous Operations of $-47.73M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$18.00M |
|
$-47.73M |
|
-- |
|
$18.00M |
|
$67.15M |
|
$-49.15M |
|
$1.45M |
|
$-47.71M |
|
$-47.71M |
|
$-47.73M |
|
|
Income from Continuous Operations |
$-47.73M |
$-47.73M |
|
$-47.73M |
|
$-49.15M |
|
$-46.10M |
|
105.33M |
|
105.33M |
|
$-0.45 |
|
$-0.45 |
|
| Balance Sheet Financials | |
$113.28M |
|
$14.29M |
|
$14.29M |
|
$127.57M |
|
$36.70M |
|
-- |
|
$35.01M |
|
$71.71M |
|
$55.86M |
|
$55.86M |
|
$55.86M |
|
105.36M |
|
| Cash Flow Statement Financials | |
$-59.73M |
|
$-1.15M |
|
$-2.08M |
|
$169.04M |
|
$104.56M |
|
$-64.48M |
|
$4.54M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.09 |
|
-- |
|
-- |
|
-- |
|
0.10 |
|
100.00% |
|
-273.14% |
|
-273.14% |
|
-256.15% |
|
-265.09% |
|
-265.21% |
|
$-60.88M |
|
-- |
|
-- |
|
-- |
|
0.14 |
|
-- |
|
2.34 |
|
156.04 |
|
-85.44% |
|
-85.44% |
|
-37.41% |
|
-85.44% |
|
$0.53 |
|
$-0.58 |
|
$-0.57 |
|